ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016Christian Dittrich, Rainer Kunstfeld, Pia Österlund et al.|ESMO Open|2016Cited by 129
Bidirectional interactions between the estrogen receptor and the c‐erbB‐2 signaling pathways: Heregulin inhibits estrogenic effects in breast cancer cellsThomas W. Grunt, Christian Dittrich, Miguel Saceda et al.|International Journal of Cancer|1995Cited by 70
Phase II study of XR 5000, an inhibitor of topoisomerases I and II, in advanced colorectal cancerFrancesco Caponigro, P. Fumoleau, Christian Dittrich et al.|European Journal of Cancer|2002Cited by 28
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumorsChristian Dittrich, Richard Greil|Investigational New Drugs|2014Cited by 18